📰 Alacyclovir News
Page 4 - Alacyclovir News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alacyclovir. Real-time updates on events, politics, business and more.
February 27, 2023
The European Unions drug regulator said on Friday its Committee for Medicinal Products for Human Use has advised against market authorisation of the COVID-19 pill from Merck for treatment in adults.
February 24, 2023
Anti-NMDA receptor encephalitis can present with psychiatric symptoms, such as depression and psychosis, and is associated with suicidal thoughts and behaviors, new research suggests.
February 22, 2023
The latest in emerging data on metformin in COVID shows benefits in viral load.
February 21, 2023
A perfect storm might be on the horizon. Are doctors and public health officials ready for a Zika resurgence?
February 21, 2023
"There are increasing reports that high-risk patients are avoiding nirmatrelvir-ritonavir due to concerns about post-Paxlovid rebound...."
February 16, 2023
The findings offer clarity amid concerns that the use of Paxlovid increased the risk for COVID-19 rebound.
February 16, 2023
The National Institutes of Health said on Wednesday that it had started a clinical trial to evaluate Shionogis experimental oral antiviral drug to treat COVID-19.
February 15, 2023
The research team observed a potential decrease in effectiveness over time, and one author called for continued monitoring.
February 13, 2023
Clinicians should be "aware that the infants of pregnant people with HCV may have a high rate of need for higher-level pediatric care."
February 11, 2023
Patients with rheumatic disease and SARS-CoV-2 infection who received outpatient treatment fared better than similar patients who did not receive treatment, but COVID-19 rebound was not infrequent in patients who received outpatient treatment.